Atahar imam Hasan: Universal Artificial Blood and the Future of Trauma Care
Atahar imam Hasan, Internship Trainee at Yacca Group, shared a post on LinkedIn:
“Japanese scientists at Nara Medical University are developing a universal artificial blood that could transform transfusion medicine.
Produced by extracting hemoglobin from expired donor blood and encapsulating it in lipid-based particles that mimic red blood cells, it can safely transport oxygen without requiring blood type matching.
Unlike donated blood, which requires refrigeration and expires in about 42 days, this artificial blood can be stored for up to two years at room temperature (or five years when refrigerated).
Its long shelf life, universal compatibility, and lower risk of transfusion-transmitted infections make it especially valuable for trauma care, disaster response, military medicine, and regions with limited blood supplies.
Human trials that began in 2022 have shown the artificial blood to be safe in healthy volunteers, with no serious side effects. Larger-dose studies (100–400 mL) are now underway to further assess its safety and effectiveness.
If successful, it could be introduced into hospitals by around 2030, marking one of the most significant advances in transfusion medicine in decades.
Source: Laws, J. (2025). Artificial Blood That Could Work for All Blood Types in Trials. Newsweek.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery